Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes
Figure 2
A significant increase in expression of CD4+IL-6+, CD4+IL-1β+, and IL-17+ T cells () and a decrease in CD4+Treg cells () were shown in all T2DM patients versus control. The expression of CD4+IL-17+ T cells was significantly higher in patients with CHD versus patients without CHD. versus healthy control subjects. versus diabetes without CHD.
